Company intelligence / Profile preview

Matriks

Turkey

Ownership: Private
Development stage: Other

Overview

Matriks Biotek is a Turkish biotechnology company founded in 2002, specializing in the production of CE IVD marked ELISA kits. They are known for being the first company to produce Shikari® ELISA kits for biological drug monitoring since 2008. Their product portfolio includes Shikari® ELISA kits, CoronaHunter® ELISA kits, and custom ELISA kits for biosimilar drugs, all produced under ISO 13485 quality system. Matriks Biotek's products are used by over 30 pharmaceutical companies globally.

Modalities: ELISA kitsIVD
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Matriks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matriks.

Explore the full profile